Traws Pharma, Inc. — Director's Dealing 2013

Dec 24, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-12-19

Reporting Person: Reddy E Premkumar (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-19	Common Stock	M	32036	$1.33	Acquired	1310754	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-19	Common Stock Option (right to buy)	$1.33	M	32036	Disposed	2014-01-01	Common Stock (32036)	Direct